News | November 02, 2023
Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr
The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202
The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202
Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
The inspection of the facility conducted from August 7 to August 11, 2023
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
With the establishment of five different precious metals alloy powder production methods
Subscribe To Our Newsletter & Stay Updated
